DDrare: Database of Drug Development for Rare Diseases

248. グルコーストランスポーター１欠損症
［臨床試験数：30，薬物数：9（DrugBank：1），標的遺伝子数：0，標的パスウェイ数：0］

Searched query = "Glucose transporter type 1 deficiency", "GLUT1 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = GLUT1 DS; Ketoflo; Keyo; Krio; TRIHEPTANOIN; TRIHEPTANOINA; Triheptanoin; Triheptanoin / Triheptanoina; UX007

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02915211 (ClinicalTrials.gov)	April 2016	19/9/2016	Evaluation of Keyo in Children With Epilepsy	A Feasibility Study to Evaluate the Acceptability of Keyo, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability	Intractable Epilepsy;Glucose Transporter Type 1 Deficiency Syndrome;Ketogenic Dieting	Dietary Supplement: Keyo	Vitaflo International, Ltd	NULL	Completed	3 Years	N/A	Both	17	N/A	United Kingdom

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02915211
(ClinicalTrials.gov)

April 2016

19/9/2016

Evaluation of Keyo in Children With Epilepsy

A Feasibility Study to Evaluate the Acceptability of Keyo, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability

Intractable Epilepsy;Glucose Transporter Type 1 Deficiency Syndrome;Ketogenic Dieting

Dietary Supplement: Keyo

Vitaflo International, Ltd

NULL

Completed

3 Years

N/A

Both

N/A

United Kingdom